The Resurgence of Gene Therapy

A reliable source for information, Liftstream is an executive search firm in Europe in the Life Sciences sector.  Here, James Sheppard of Liftstream writes about the promise gene therapy holds for many in rare disease research.

Gene therapy has a chequered past and is still capable of drawing strong opinions both for and against its use. The recently European approval of Glybera (UniQure) for the treatment of lipoprotein lipase deficiency (LPLD) has been seen by many as a turning point for the technology. Liftstream takes a look here at the recent past of gene therapy and what the future has in store.

The Resurgence of Gene Therapy.

Advertisements